Jinling Pharmaceutical Co Ltd (000919) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million ≈ $10.83 Million USD) by net assets (CN¥4.85 Billion ≈ $709.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Jinling Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Jinling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jinling Pharmaceutical Co Ltd (000919) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd SHE:300384	-0.003x
Guangdong Super Telecom SHG:603322	0.053x
Jiangsu Liba Enterprise Joint-Stock Co Ltd SHG:603519	0.051x
Bridgewater Bancshares Inc NASDAQ:BWB	0.030x
Willis Lease Finance Corporation NASDAQ:WLFC	0.082x
Redwood Trust Inc NYSE:RWT	-4.710x
Dream Unlimited Corp TO:DRM	0.032x
Foshan Nationstar Optoelectronics Co Ltd SHE:002449	0.024x

Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 000919 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.85 Billion ≈ $709.50 Million	CN¥154.19 Million ≈ $22.56 Million	0.032x	-26.26%
2023-12-31	CN¥3.68 Billion ≈ $539.22 Million	CN¥158.92 Million ≈ $23.26 Million	0.043x	-39.97%
2022-12-31	CN¥3.63 Billion ≈ $530.75 Million	CN¥260.59 Million ≈ $38.13 Million	0.072x	-13.04%
2021-12-31	CN¥3.53 Billion ≈ $517.22 Million	CN¥292.03 Million ≈ $42.73 Million	0.083x	-8.93%
2020-12-31	CN¥3.43 Billion ≈ $502.38 Million	CN¥311.46 Million ≈ $45.58 Million	0.091x	-33.30%
2019-12-31	CN¥3.42 Billion ≈ $501.14 Million	CN¥465.85 Million ≈ $68.17 Million	0.136x	+1.78%
2018-12-31	CN¥3.25 Billion ≈ $475.00 Million	CN¥433.83 Million ≈ $63.48 Million	0.134x	-7.89%
2017-12-31	CN¥3.05 Billion ≈ $446.88 Million	CN¥443.11 Million ≈ $64.84 Million	0.145x	+360.72%
2016-12-31	CN¥3.05 Billion ≈ $446.75 Million	CN¥96.15 Million ≈ $14.07 Million	0.031x	-56.65%
2015-12-31	CN¥2.92 Billion ≈ $427.95 Million	CN¥212.45 Million ≈ $31.09 Million	0.073x	-33.36%
2014-12-31	CN¥2.75 Billion ≈ $402.55 Million	CN¥299.89 Million ≈ $43.88 Million	0.109x	+3.48%
2013-12-31	CN¥2.57 Billion ≈ $376.72 Million	CN¥271.21 Million ≈ $39.69 Million	0.105x	+11.91%
2012-12-31	CN¥2.47 Billion ≈ $360.82 Million	CN¥232.12 Million ≈ $33.97 Million	0.094x	+26.66%
2011-12-31	CN¥2.33 Billion ≈ $340.26 Million	CN¥172.82 Million ≈ $25.29 Million	0.074x	-8.07%
2010-12-31	CN¥2.20 Billion ≈ $321.83 Million	CN¥177.81 Million ≈ $26.02 Million	0.081x	-11.82%
2009-12-31	CN¥2.05 Billion ≈ $300.70 Million	CN¥188.41 Million ≈ $27.57 Million	0.092x	-43.58%
2008-12-31	CN¥1.88 Billion ≈ $274.89 Million	CN¥305.26 Million ≈ $44.67 Million	0.162x	+168.31%
2007-12-31	CN¥1.95 Billion ≈ $285.26 Million	CN¥118.06 Million ≈ $17.28 Million	0.061x	-25.72%
2006-12-31	CN¥1.70 Billion ≈ $248.57 Million	CN¥138.50 Million ≈ $20.27 Million	0.082x	+16.56%
2005-12-31	CN¥1.56 Billion ≈ $228.64 Million	CN¥109.29 Million ≈ $15.99 Million	0.070x	-35.69%
2004-12-31	CN¥1.47 Billion ≈ $214.99 Million	CN¥159.81 Million ≈ $23.38 Million	0.109x	-7.32%
2003-12-31	CN¥1.38 Billion ≈ $201.81 Million	CN¥161.86 Million ≈ $23.69 Million	0.117x	+11.72%
2002-12-31	CN¥1.24 Billion ≈ $181.58 Million	CN¥130.36 Million ≈ $19.08 Million	0.105x	+26.04%
2001-12-31	CN¥1.11 Billion ≈ $162.39 Million	CN¥92.49 Million ≈ $13.53 Million	0.083x	-61.78%
2000-12-31	CN¥1.06 Billion ≈ $155.22 Million	CN¥231.31 Million ≈ $33.85 Million	0.218x	+458.19%
1999-12-31	CN¥1.02 Billion ≈ $148.96 Million	CN¥39.77 Million ≈ $5.82 Million	0.039x	--

About Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic

Market Cap

$578.81 Million

CN¥3.96 Billion CNY

Market Cap Rank

#11349 Global

#3143 in China

Share Price

CN¥6.36

Change (1 day)

+1.11%

52-Week Range

CN¥5.78 - CN¥8.91

All Time High

CN¥16.21